Valvular Aortic Stenosis Prognosis Study
Condition(s) studied
Investigational drug(s) / intervention(s)
Transthoracic ultrasound: Patients are prospectively identified during echocardiography performed in the echocardiography laboratory of the two participating centers when a diagnosis of aortic stenosis is made.
Study summary
Aortic stenosis is the most common valvulopathy in Western countries. Cardiac EchoDoppler is the reference method for assessment of aortic stenosis and provides prognostic elements. However, it is imperfect with many inconsistencies between measures. On the other hand, the prognosis of patients with low flow and low gradient aortic retraction is discussed.
The main objective of this work is to study the prognosis of asymptomatic and symptomatic aortic retraction.
Eligibility
Primary outcome measure(s)
- Prognosis of asymptomatic and symptomatic aortic valve stenosis — 6 years
Aortic valve stenosis (Rao) is the most common valvulopathy in Western countries. Cardiac EchoDoppler represents the reference method of evaluation of Rao and provides prognostic elements. However, it is imperfect with many inconsistencies between measures. On the other hand, the prognosis of patients with low-gradient and low-gradient Rao is discussed.) The main objective of this work is to study the prognosis of asymptomatic and symptomatic aortic valve stenosis. To Look for predictors of prognosis and To Evaluate the impact of comorbidities on the prognosis of RAo Evaluate operative indications and specify the short and long term outcome after surgery.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Chu Amiens-Picardie | Amiens | France | Recruiting |
More Centre Hospitalier Universitaire, Amiens trials in France
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03628313 on ClinicalTrials.gov ↗ ← All trials in France